Morgan Stanley
RXST icon

Morgan Stanley’s RxSight RXST Stock Holding History

Morgan Stanley’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.5M Sell
311,765
-298,139
-49% -$1.8M ﹤0.01% 5016
2026
Q1 		$3.76M Sell
609,904
-155,121
-20% -$1.29M ﹤0.01% 4339
2025
Q4 		$7.97M Sell
765,025
-79,628
-9% -$799K ﹤0.01% 3803
2025
Q3 		$7.59M Sell
844,653
-157,070
-16% -$1.38M ﹤0.01% 3798
2025
Q2 		$13M Buy
1,001,723
+595,337
+146% +$8.95M ﹤0.01% 3200
2025
Q1 		$10.3M Buy
406,386
+14,187
+4% +$422K ﹤0.01% 3318
2024
Q4 		$13.5M Sell
392,199
-94,701
-19% -$4.27M ﹤0.01% 3124
2024
Q3 		$24.1M Sell
486,900
-630,358
-56% -$32.3M ﹤0.01% 2614
2024
Q2 		$67.2M Sell
1,117,258
-8,393
-0.7% -$480K 0.01% 1475
2024
Q1 		$58.1M Buy
1,125,651
+52,589
+5% +$2.58M ﹤0.01% 1617
2023
Q4 		$43.3M Sell
1,073,062
-138,342
-11% -$4.06M ﹤0.01% 1877
2023
Q3 		$33.8M Sell
1,211,404
-295,671
-20% -$8.82M ﹤0.01% 1925
2023
Q2 		$43.4M Buy
1,507,075
+1,451,598
+2,617% +$32.3M ﹤0.01% 1698
2023
Q1 		$925K Buy
55,477
+32,008
+136% +$452K ﹤0.01% 4905
2022
Q4 		$297K Sell
23,469
-3,735
-14% -$45.4K ﹤0.01% 5496
2022
Q3 		$326K Buy
27,204
+17,708
+186% +$243K ﹤0.01% 5487
2022
Q2 		$134K Buy
9,496
+5,964
+169% +$78.7K ﹤0.01% 6116
2022
Q1 		$44K Buy
3,532
+1,515
+75% +$18.2K ﹤0.01% 6769
2021
Q4 		$23K Buy
2,017
+478
+31% +$5.75K ﹤0.01% 7171
2021
Q3 		$19K Buy
+1,539
New +$21.2K ﹤0.01% 7119

Other funds holding RXST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.66B AUM 39.91% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Morgan Stanley's RXST Position: Q2 2026 in Review

Morgan Stanley reduced its RxSight (RXST) stake by 49% in Q2 2026, selling an estimated $1.8M and leaving 311,765 shares worth $1.5M. The position accounts for ﹤0.01% of the portfolio, ranked #5016.

Morgan Stanley first reported a position in RXST in Q3 2021 and has held it in 20 quarters since. The position peaked at $67.2M in Q2 2024. 151 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

  • Morgan Stanley held 311,765 shares of RxSight worth $1.5M as of Q2 2026.
  • Morgan Stanley sold 298,139 RxSight shares in Q2 2026, an estimated $1.8M.
  • RxSight made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #5016 holding.
  • Morgan Stanley first reported a position in RxSight in Q3 2021 and has held it in 20 quarters since.
  • Morgan Stanley's RxSight position peaked at $67.2M in Q2 2024.
  • 151 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.